Transaction overview
Motus acquired Everlance, a mileage and expense tracking solution provider founded in 2015 by Alex Marlantes and Gabriel Garza, on February 19, 2025. The deal closed on the same day with no financial details disclosed. Motus aims to strengthen its position as an industry leader in vehicle reimbursement solutions for businesses of all sizes.
Deal structure and financing
The transaction's exact terms remain undisclosed, including any equity or debt split, lead banks, leverage metrics, and seller retained stake information. No lock-up periods or IPO optionality were mentioned. Given the lack of specific financial details, it is challenging to provide a comprehensive overview of the deal's financing.
Strategic context
Motus' acquisition of Everlance is driven by the company's strategic objective to enhance its vehicle reimbursement offerings through integrating innovative expense tracking solutions. Everlance’s automated mileage and expense logging capabilities complement Motus’ existing product suite, supporting mobile workers across various industries. The integration aims to improve user experience and operational efficiency for businesses managing employee reimbursements.
Everlance was initially backed by Moderne Ventures, indicating a strategic partnership that facilitated its growth in the expense management space. The company's technology has been instrumental in helping over 4 million drivers track their miles automatically and log expenses efficiently. This acquisition represents Motus’s commitment to expanding its market reach and addressing evolving needs within the vehicle reimbursement sector.
Regulatory path
The transaction did not require regulatory approvals from any known governing bodies, as no specific information about filings or remedies was disclosed. Given the deal's undisclosed financial terms, it is unclear whether HSR filing requirements were met in the United States. However, considering Motus and Everlance’s primary focus on North American markets, the lack of announced regulatory hurdles suggests a relatively straightforward path to closing without significant antitrust concerns or divestiture obligations.